Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Olland

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|May 2, 2013
Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysisOleg V Kovalenko, Andrea Olland, Nicole Piché-Nicholas, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonistsRonald C Bernotas, Robert R Singhaus, David H Kaufman, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2010
Pyridinyl aminohydantoins as small molecule BACE1 inhibitorsPing Zhou, Yanfang Li, Yi Fan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2011
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft modelChristoph W Zapf, Jonathan D Bloom, Zhong Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2010
Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Yu Hui, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
RSC Medicinal Chemistry|April 18, 2022
The identification of highly efficacious functionalised tetrahydrocyclopenta[<i>c</i>]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assemblyAndrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaprogetAndrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|May 2, 2013
Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysisOleg V Kovalenko, Andrea Olland, Nicole Piché-Nicholas, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonistsRonald C Bernotas, Robert R Singhaus, David H Kaufman, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2010
Pyridinyl aminohydantoins as small molecule BACE1 inhibitorsPing Zhou, Yanfang Li, Yi Fan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2011
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft modelChristoph W Zapf, Jonathan D Bloom, Zhong Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2010
Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Yu Hui, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
RSC Medicinal Chemistry|April 18, 2022
The identification of highly efficacious functionalised tetrahydrocyclopenta[<i>c</i>]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assemblyAndrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaprogetAndrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Pageof 3